KISPLYX caps 4 mg 30 pce

7680660850011 CH-66085 L01EX08 07.16.1.

Reimbursement limitations:

KISPLYX.01

1L carcinome à cellules rénales avancé (non résécable ou métastatique) présentant un profil de risque …

KISPLYX caps 4 mg 30 pce
KISPLYX caps 4 mg 30 pce
KISPLYX caps 4 mg 30 pce
1 / 3
google

Details

Product number
6608501
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
lenvatinibum 4 mg ut lenvatinibi mesilas, calcii carbonas, mannitolum, cellulosum microcristallinum, hydroxypropylcellulosum, hydroxypropylcellulosum substitutum humile, talcum, Kapselhülle: hypromellosum, E 171, E 172 (flavum), E 172 (rubrum), Drucktinte: lacca, E 172 (nigrum), kalii hydroxidum, propylenglycolum, pro capsula.

Articles (1)

Kisplyx 4 mg, Kapseln
Kapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
17/10/2025
Professional SmPC
Français
17/10/2025
Professional SmPC
Italien
17/10/2025
Patient information leaflet
Allemand
23/08/2025
Patient information leaflet
Français
23/08/2025
Patient information leaflet
Italien
23/08/2025

Detailed composition

Substance Quantity Type Category
(N/A)
4.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)

Reimbursement information

Public price
CHF 1376.30
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/07/2025

Authorization holder

Eisai Pharma AG

8050 Zürich

Authorization information

Swissmedic authorization number
66085
Drug name
Kisplyx, Kapseln
Galenic form
KAHA
ATC Code
L01EX08
Authorization status
Z
Dispensation category
A
First authorization
25/08/2017
Authorization expiration date
31/12/9999
IT number
07.16.1.
Domain
Human medicine
Field of application
Behandlung von fortgeschrittenem Nierenzellkarzinom (RCC)

Packaging details

Description (FR)
KISPLYX caps 4 mg 30 pce
Description (DE)
KISPLYX Kaps 4 mg 30 Stk
Market launch
25/08/2017
Narcotic (BTM)
No

Other packaging sizes

KISPLYX caps 10 mg 30 pce
30 KAP
GTIN: 7680660850028
View